Literature DB >> 12015198

Endocannabinoids and cannabinoid receptor genetics.

Emmanuel S Onaivi1, Claire M Leonard, Hiroki Ishiguro, Ping Wu Zhang, Zhicheng Lin, Babatunde E Akinshola, George R Uhl.   

Abstract

This review presents the remarkable advances that have been achieved in marijuana (cannabinoid) research, with the discovery of specific receptors and the existence of naturally occurring cannabis-like substances in the human body and brain. The last decade has seen more rapid progress in marijuana research than any time in the thousands of years that marijuana has been used by humans, particularly in cannabinoid genomics. The cDNA and genomic sequences encoding G protein-coupled cannabinoid receptors (Cnrs) from several species have now been cloned. Endogenous cannabinoids (endocannabinoids), synthetic and hydrolyzing enzymes and transporters that define neurochemically-specific cannabinoid brain pathways have been identified. Endocannabinoid lipid signaling molecules alter activity at G protein-coupled receptors (GPCR) and possibly at anandamide-gated ion channels, such as vanilloid receptors. Availability of increasingly-specific CB1 and CB2 Cnr antagonists and of CB1 and CB2 Cnr knockout mice have increased our understanding of these cannabinoid systems and provides tantalizing evidence for even more G protein-coupled Cnrs. Initial studies of the Cnr gene structure, regulation and polymorphisms whet our appetite for more information about these interesting genes, their variants and roles in vulnerabilities to addictions and other neuropsychiatric disorders. Behavioral studies of cannabinoids document the complex interactions between rewarding and aversive effects of these drugs. Pursuing cannabinoid-related molecular, pharmacological and behavioral leads will add greatly to our understanding of endogenous brain neuromodulator systems, abused substances and potential therapeutics. This review of CB1 and CB2 Cnr genes in human and animal brain and their neurobiological effects provide a basis for many of these studies. Therefore, understanding the physiological cannabinoid control system in the human body and brain will contribute to elucidating this natural regulatory mechanism in health and disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12015198     DOI: 10.1016/s0301-0082(02)00007-2

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  19 in total

1.  Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain.

Authors:  Michiru Hirasawa; Yannick Schwab; Sirajedin Natah; Cecilia J Hillard; Ken Mackie; Keith A Sharkey; Quentin J Pittman
Journal:  J Physiol       Date:  2004-07-14       Impact factor: 5.182

2.  Endocannabinoid signaling directs differentiation of trophoblast cell lineages and placentation.

Authors:  Xiaofei Sun; Huirong Xie; Jie Yang; Haibin Wang; Heather B Bradshaw; Sudhansu K Dey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

3.  Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents.

Authors:  Christian J Hopfer; Susan E Young; Shaun Purcell; Thomas J Crowley; Michael C Stallings; Robin P Corley; Soo Hyun Rhee; Andrew Smolen; Ken Krauter; John K Hewitt; Marissa A Ehringer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-12-05       Impact factor: 3.568

4.  The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology.

Authors:  Iram P Rodriguez-Sanchez; Josee Guindon; Marco Ruiz; M Elizabeth Tejero; Gene Hubbard; Laura E Martinez-de-Villarreal; Hugo A Barrera-Saldaña; Edward J Dick; Anthony G Comuzzie; Natalia E Schlabritz-Loutsevitch
Journal:  Neurotoxicol Teratol       Date:  2016-06-18       Impact factor: 3.763

5.  The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults.

Authors:  Christie A Hartman; Christian J Hopfer; Brett Haberstick; Soo Hyun Rhee; Thomas J Crowley; Robin P Corley; John K Hewitt; Marissa A Ehringer
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

6.  Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.

Authors:  Heather M Haughey; Erin Marshall; Joseph P Schacht; Ashleigh Louis; Kent E Hutchison
Journal:  Addiction       Date:  2008-08-14       Impact factor: 6.526

Review 7.  The neurobiology of individual differences in complex behavioral traits.

Authors:  Ahmad R Hariri
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

8.  Cnr2 deficiency confers resistance to inflammation-induced preterm birth in mice.

Authors:  Xiaofei Sun; Monica Cappelletti; Yingju Li; Christopher L Karp; Senad Divanovic; Sudhansu K Dey
Journal:  Endocrinology       Date:  2014-07-22       Impact factor: 4.736

9.  Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function.

Authors:  Ahmad R Hariri; Adam Gorka; Luke W Hyde; Mark Kimak; Indrani Halder; Francesca Ducci; Robert E Ferrell; David Goldman; Stephen B Manuck
Journal:  Biol Psychiatry       Date:  2008-12-21       Impact factor: 13.382

10.  Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of the CNR1 and FAAH endocannabinoid genes, and the 3' region of the DRD2 gene.

Authors:  Janet Hoenicka; Guillermo Ponce; Miguel A Jiménez-Arriero; Israel Ampuero; Roberto Rodríguez-Jiménez; Gabriel Rubio; Maria Aragüés; Jose A Ramos; Tomás Palomo
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.